Killing malignant mitochondria is one of the most promising approaches in the development of new anticancer drugs. Scientists have now synthesized a copper-containing peptide that is readily taken up by mitochondria in breast cancer stem cells, where it effectively induces apoptosis. The study also highlights the powerful therapeutic potential of the metallopeptides.
from Top Technology News -- ScienceDaily http://ift.tt/2Bmmshx
via IFTTT
Technology and Professional News
IFTTT
Top Technology News -- ScienceDaily
A metallopeptide targets and disrupts mitochondrial function in breast cancer stem cells
Next
« Prev Post
« Prev Post
Previous
Next Post »
Next Post »
Subscribe to:
Post Comments (Atom)
EmoticonEmoticon